Victory Capital Management Inc. acquired a new stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 13,340 shares of the company’s stock, valued at approximately $54,000. A number of other hedge funds […]